Simply confirm your registered email address below and click "Reset Password." We will immediately email you a link back to the site where you can enter a new password for this account.
We've found your existing WIBC Email Club account. Please login below to complete the Facebook login process.
Pharmaceutical Compounding has been in the spotlight since a fungal meningitis outbreak has sickened more than 200 people and killed 15. But how does a lab end up with tainted products, like a fungus growing in a steroid compound?
Amy Peak with the College of Pharmacy at Butler University says there was almost a perfect storm that caused the fungal meningitis outbreak.
Peak says a combination of a huge compounding pharmacy, a product that can't be produced with preservatives, along with an epidural that is injected into the spinal column, set the stage for a lot of people to get very ill.
Compounding Pharmacies are typically a lot smaller, according to Peak, who says operating at such a large scale, as the New England Compounding Center was, could easily lead to a large amount of tainted products that are distributed nationally.
MORE FROM WIBC NEWS: » Second Death in Indiana from Fungal Meningitis Outbreak (10-13-12) » Three More Meningitis Cases Confirmed in Indiana (10-12-12) » Patient Injected in Indiana Becomes State's First Meningitis Death (10-11-12) » Number of Fungal Meningitis Cases Climbs to 11 in Indiana (10-8-12) » Fungal Meningitis Cases Jump In Indiana (10-7-12) » Cases of Fungal Meningitis Climbs to Three in Indiana (10-5-12) » Doctor Explains Fungal Meningitis (10-5-12) » Rare Fungal Meningitis Spreads to Indiana (10-4-12)
NOTE: This thread is moderated, comments will not post immediately.
Copyright by WIBC.com © 2012. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Copyright © 2014. All rights reserved.